A Whole-blood Transcriptional Signature Associated With Obstructive Post-tuberculosis Lung Disease
Open Access
- 29 September 2026
- journal article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (10)
Abstract
Background: Post-tuberculosis (TB) lung disease (PTLD) affects ∼50% of persons with pulmonary TB (PTB). We recently discovered whole blood transcriptional signatures associated with PTLD. We examined whether a minimum gene signature predicts PTLD as a clinically useful biomarker. Methods: We prospectively enrolled 301 treatment naive adults with newly diagnosed PTB (cohort A). We collected whole blood at 0 and 6-month visits, isolated RNA, and measured a modified MTB host response (HR) signature (mHR) based on expression of DUSP3, GBP5, and TMBIM6. We recorded spirometry at 6 (n = 216) and 12 months (n = 210) after treatment initiation and examined the association of the mHR score with PTLD and Mtb aerosolization. We recruited household contacts of cohort A to compare mHR score with non-PTB participants (cohort B). Results: mHR was associated with TB (P = 4.15e−66) when compared to HHCs, treatment response (P = 1.07e−53), and characteristics including CD4 count (P = .003), bacillary load (P = 3.02e−05), lung cavities (P = 1.59e−04), and lung quadrants involved (P = 3.87e−06). The mHR score was not associated with Mtb aerosolization. In total, 105 (50%) participants had PTLD at 12 months including 61 with restriction, 26 with obstruction, and 18 with mixed obstruction and restriction. Baseline mHR was associated with obstructive PTLD at both 6 (P = .003) and 12 months (P = .012) in bivariate and multivariate analyses. The mHR score was not associated with restrictive lung disease. Conclusions: Baseline mHR was associated with obstructive PTLD at 6 and 12 months and may have applications in targeting treatment and prognostication.Keywords
Funding Information
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Norges Idrettshøgskole (5R01AI150815)
- Norges Idrettshøgskole (UH2AI152621)
- Norges Idrettshøgskole (UL1 TR002319)
- Norges Idrettshøgskole (D43 TW011817-01)
- National Center for Advancing Translational Sciences
- Firland Foundation
- National Heart, Lung, and Blood Institute (5K23HL164289)
- J.S.Z.
- Division of Intramural Research
This publication has 39 references indexed in Scilit:
- RNA-binding protein AZGP1 inhibits epithelial cell proliferation by regulating the genes of alternative splicing in COPDGene, 2024
- Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multicentre prospective study in low-income and middle-income countriesThe Lancet Infectious Diseases, 2023
- Guanylate-binding proteins: mechanisms of pattern recognition and antimicrobial functionsTrends in Biochemical Sciences, 2023
- Blood-based host biomarker diagnostics in active case finding for pulmonary tuberculosis: A diagnostic case-control studyeClinicalMedicine, 2021
- Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment ResponseJAMA Network Open, 2018
- A blood RNA signature for tuberculosis disease risk: a prospective cohort studyThe Lancet, 2016
- Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 InfectivityCell Host & Microbe, 2016
- Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysisThe Lancet Respiratory Medicine, 2016
- Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational studyThe Lancet Global Health, 2015
- Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysisThe Lancet Respiratory Medicine, 2014